BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21219705)

  • 1. Blood, urine, and hair kinetic analysis following an acute lead intoxication.
    Ho G; Keutgens A; Schoofs R; Kotolenko S; Denooz R; Charlier C
    J Anal Toxicol; 2011 Jan; 35(1):60-4. PubMed ID: 21219705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chelation therapy in children exposed to lead.
    Shannon M; Woolf A; Binns H
    N Engl J Med; 2001 Oct; 345(16):1212-3. PubMed ID: 11642245
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combined chelation in lead intoxication.
    Tandon SK; Singh S; Jain VK
    Chem Res Toxicol; 1994; 7(5):585-9. PubMed ID: 7841335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
    Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
    J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acid.
    Slikkerveer A; Noach LA; Tytgat GN; Van der Voet GB; De Wolff FA
    Analyst; 1998 Jan; 123(1):91-2. PubMed ID: 9581027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meso-2,3-dimercaptosuccinic acid in the treatment of occupationally exposed lead workers.
    Restek-Samarzija N; Blanusa M; Pizent A; Samarzija M; Turk R; Corović N; Jurasović J
    Arh Hig Rada Toksikol; 1998 Jun; 49(2):137-45. PubMed ID: 9919719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review.
    Muran PJ
    Altern Ther Health Med; 2006; 12(3):70-5. PubMed ID: 16708769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
    Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neither DMPS nor DMSA is effective in quantitative elimination of elemental mercury after intentional IV injection.
    Eyer F; Felgenhauer N; Pfab R; Drasch G; Zilker T
    Clin Toxicol (Phila); 2006; 44(4):395-7. PubMed ID: 16809143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
    Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
    Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate in chronic arsenic intoxication in rats.
    Flora SJ; Dube SN; Arora U; Kannan GM; Shukla MK; Malhotra PR
    Biometals; 1995 Apr; 8(2):111-6. PubMed ID: 7734923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succimer (meso-2,3-dimercaptosuccinic acid (DMSA)) treatment of Andean children with environmental lead exposure.
    Counter SA; Ortega F; Shannon MW; Buchanan LH
    Int J Occup Environ Health; 2003; 9(2):164-8. PubMed ID: 12848245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of severe poisoning with thiomersal.
    Pfab R; Mückter H; Roider G; Zilker T
    J Toxicol Clin Toxicol; 1996; 34(4):453-60. PubMed ID: 8699562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
    Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
    Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children.
    Chisolm JJ
    J Toxicol Clin Toxicol; 1992; 30(4):493-504. PubMed ID: 1331490
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric lead poisoning from folk prescription for treating epilepsy.
    Ying XL; Xu J; Markowitz M; Yan CH
    Clin Chim Acta; 2016 Oct; 461():130-4. PubMed ID: 27481338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.